Fungal infections as a complication of therapy for sarcoidosis
Identifieur interne : 001E71 ( Main/Exploration ); précédent : 001E70; suivant : 001E72Fungal infections as a complication of therapy for sarcoidosis
Auteurs : R. P. Baughman [États-Unis] ; E. E. Lower [États-Unis]Source :
- QJM [ 1460-2725 ] ; 2005.
Abstract
Background: Treatment of symptomatic sarcoidosis usually includes systemic immunosuppressive agents. These agents may render the patient more susceptible to opportunistic infections. In addition, the fungal infection may be difficult to distinguish from the underlying sarcoidosis. Aim: To examine the presentation and management of invasive fungal infections in sarcoidosis patients. Design: Retrospective record review. Methods: We reviewed the notes of all sarcoidosis patients (n = 753) seen at our clinic over an 18-month period. Results: Seven patients (0.9%) with previously diagnosed sarcoidosis developed fungal infections: two each with Histoplasma capsulatum and Blastomyces dermatitidis and three others with Cryptococcus neoformans. No cases of invasive aspergillus or tuberculosis were identified. The diagnosis of fungal infection was made by bronchoscopy (four cases), open-lung biopsy (one case), bone-marrow aspirate (one case), and spinal fluid examination (one case). All patients were receiving corticosteroids at the time of worsening chest X-ray or clinical status. Four patients were also receiving methotrexate prior to infection. No patient with systemic fungal infection was receiving either infliximab or cyclophosphamide. All patients responded to anti-fungal therapy and a reduction in immunosuppression. Discussion: Fungal infections occur rarely in treated patients with sarcoidosis. Deterioration of chest X-ray, especially a localized infiltrate, warrants investigation.
Url:
DOI: 10.1093/qjmed/hci073
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000164
- to stream Istex, to step Curation: 000164
- to stream Istex, to step Checkpoint: 000D21
- to stream Main, to step Merge: 001E85
- to stream Main, to step Curation: 001E71
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Fungal infections as a complication of therapy for sarcoidosis</title><author><name sortKey="Baughman, R P" sort="Baughman, R P" uniqKey="Baughman R" first="R. P." last="Baughman">R. P. Baughman</name></author><author><name sortKey="Lower, E E" sort="Lower, E E" uniqKey="Lower E" first="E. E." last="Lower">E. E. Lower</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A2D983100E827D816FB6CC0801D133AA67049B2D</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1093/qjmed/hci073</idno><idno type="url">https://api.istex.fr/ark:/67375/HXZ-20CR1H35-F/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000164</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000164</idno><idno type="wicri:Area/Istex/Curation">000164</idno><idno type="wicri:Area/Istex/Checkpoint">000D21</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D21</idno><idno type="wicri:doubleKey">1460-2725:2005:Baughman R:fungal:infections:as</idno><idno type="wicri:Area/Main/Merge">001E85</idno><idno type="wicri:Area/Main/Curation">001E71</idno><idno type="wicri:Area/Main/Exploration">001E71</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Fungal infections as a complication of therapy for sarcoidosis</title><author><name sortKey="Baughman, R P" sort="Baughman, R P" uniqKey="Baughman R" first="R. P." last="Baughman">R. P. Baughman</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati</wicri:regionArea><wicri:noRegion>Cincinnati</wicri:noRegion></affiliation></author><author><name sortKey="Lower, E E" sort="Lower, E E" uniqKey="Lower E" first="E. E." last="Lower">E. E. Lower</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From the Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati</wicri:regionArea><wicri:noRegion>Cincinnati</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">QJM</title><title level="j" type="abbrev">QJM</title><idno type="ISSN">1460-2725</idno><idno type="eISSN">1460-2393</idno><imprint><publisher>Oxford University Press</publisher><date type="e-published" when="2005-05-06">2005</date><date when="2005-06">2005</date><biblScope unit="vol">98</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="451">451</biblScope><biblScope unit="page" to="456">456</biblScope></imprint><idno type="ISSN">1460-2725</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1460-2725</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Treatment of symptomatic sarcoidosis usually includes systemic immunosuppressive agents. These agents may render the patient more susceptible to opportunistic infections. In addition, the fungal infection may be difficult to distinguish from the underlying sarcoidosis. Aim: To examine the presentation and management of invasive fungal infections in sarcoidosis patients. Design: Retrospective record review. Methods: We reviewed the notes of all sarcoidosis patients (n = 753) seen at our clinic over an 18-month period. Results: Seven patients (0.9%) with previously diagnosed sarcoidosis developed fungal infections: two each with Histoplasma capsulatum and Blastomyces dermatitidis and three others with Cryptococcus neoformans. No cases of invasive aspergillus or tuberculosis were identified. The diagnosis of fungal infection was made by bronchoscopy (four cases), open-lung biopsy (one case), bone-marrow aspirate (one case), and spinal fluid examination (one case). All patients were receiving corticosteroids at the time of worsening chest X-ray or clinical status. Four patients were also receiving methotrexate prior to infection. No patient with systemic fungal infection was receiving either infliximab or cyclophosphamide. All patients responded to anti-fungal therapy and a reduction in immunosuppression. Discussion: Fungal infections occur rarely in treated patients with sarcoidosis. Deterioration of chest X-ray, especially a localized infiltrate, warrants investigation.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Baughman, R P" sort="Baughman, R P" uniqKey="Baughman R" first="R. P." last="Baughman">R. P. Baughman</name></noRegion><name sortKey="Lower, E E" sort="Lower, E E" uniqKey="Lower E" first="E. E." last="Lower">E. E. Lower</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E71 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E71 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:A2D983100E827D816FB6CC0801D133AA67049B2D
|texte= Fungal infections as a complication of therapy for sarcoidosis
}}
| This area was generated with Dilib version V0.6.33. |  |